Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Management Changes

3rd Mar 2025 14:00

RNS Number : 1377Z
Ovoca Bio PLC
03 March 2025
 

 

Ovoca Bio PLC

3 March 2025

 

 

Ovoca Bio plc

 ("Ovoca" or the "Company")

 

Management Changes

 

Dublin, Ireland, 3 March 2025 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, is pleased to announce the appointment of Ms. Leah O'Donovan as its Chief Financial Officer with immediate effect.

 

Ms. O'Donovan is a professional accountant with over 15 years' experience working in the accounting and financial services industries. Prior to joining Ovoca, she was a Senior Financial Controller at Grant Thornton, Senior Financial Accountant at CNP Santander Insurance, and worked at such institutions as MetLife and Maples Fiduciary Services.

 

Timothy McCutcheon, Ovoca's CEO, said "We welcome Leah to our team and look forward to working with her for the benefit of all Ovoca stakeholders. I would like to thank Dmitriy Nikitashenko for his service and wish him well in his future endeavors."

 

The role of Chief Financial Officer is not a Board position at present.

 

 

End

 

For further information:

 

Ovoca Bio plc

Timothy McCutcheon (Chief Executive)

Tel +353 1 661 9819

[email protected]

 

Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)

Ivan Murphy / Daragh O'Reilly

Tel: +353 1 679 6363

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOSORVOUORAR

Related Shares:

Ovoca Bio
FTSE 100 Latest
Value8,417.34
Change2.09